GT200600119A - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
GT200600119A
GT200600119A GT200600119A GT200600119A GT200600119A GT 200600119 A GT200600119 A GT 200600119A GT 200600119 A GT200600119 A GT 200600119A GT 200600119 A GT200600119 A GT 200600119A GT 200600119 A GT200600119 A GT 200600119A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical compositions
humid
preparation
granulation process
therapeutic substance
Prior art date
Application number
GT200600119A
Other languages
English (en)
Inventor
Katja Jores
Andreas Meyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600119A publication Critical patent/GT200600119A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA A COMPOSICIONES FARMACÉUTICAS ESPECÍFICAMENTE A PROCESO DE GRANULACIÓN VIA HÚMEDA PARA LA PREPARACIÓN DE GRÁNULOS QUE CONTIENE UNA SUSTANCIA TERAPÉUTICA QUE PUEDEN SER UTILIZADOS PARA PREPARAR COMPOSICIONES FARMACÉUTICAS.
GT200600119A 2005-03-24 2006-03-17 Composiciones farmaceuticas GT200600119A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66473305P 2005-03-24 2005-03-24

Publications (1)

Publication Number Publication Date
GT200600119A true GT200600119A (es) 2006-10-25

Family

ID=37024189

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600119A GT200600119A (es) 2005-03-24 2006-03-17 Composiciones farmaceuticas

Country Status (15)

Country Link
US (1) US20080207533A1 (es)
EP (1) EP1865926A2 (es)
JP (1) JP2008546635A (es)
KR (1) KR20080011278A (es)
CN (1) CN101146519A (es)
AR (1) AR052952A1 (es)
AU (1) AU2006226521A1 (es)
BR (1) BRPI0609442A2 (es)
CA (1) CA2602000A1 (es)
GT (1) GT200600119A (es)
MX (1) MX2007011704A (es)
PE (1) PE20061352A1 (es)
RU (1) RU2007139105A (es)
TW (1) TW200724168A (es)
WO (1) WO2006100087A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CN1315862C (zh) 2000-05-26 2007-05-16 艾登尼科斯（开曼）有限公司 处理黄病毒和瘟病毒的方法和组合物
EP1576138B1 (en) 2002-11-15 2017-02-01 Idenix Pharmaceuticals LLC. 2'-methyl nucleosides in combination with interferon and flaviviridae mutation
JP5527921B2 (ja) * 2006-12-22 2014-06-25 エスエス製薬株式会社 苦味を隠蔽した経口固形組成物
TWI637744B (zh) * 2013-07-31 2018-10-11 中外製藥股份有限公司 含有胺基吡唑衍生物之醫藥製劑

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456155B2 (en) * 2002-06-28 2008-11-25 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections

Also Published As

Publication number Publication date
MX2007011704A (es) 2007-11-15
AR052952A1 (es) 2007-04-11
TW200724168A (en) 2007-07-01
BRPI0609442A2 (pt) 2010-04-06
JP2008546635A (ja) 2008-12-25
KR20080011278A (ko) 2008-02-01
WO2006100087A3 (en) 2007-02-15
EP1865926A2 (en) 2007-12-19
CN101146519A (zh) 2008-03-19
AU2006226521A1 (en) 2006-09-28
WO2006100087A2 (en) 2006-09-28
CA2602000A1 (en) 2006-09-28
US20080207533A1 (en) 2008-08-28
RU2007139105A (ru) 2009-04-27
PE20061352A1 (es) 2007-01-11

Similar Documents

Publication Publication Date Title
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
CR10479A (es) Modulares bencimidazolicos de vr1
SV2011003786A (es) Compuestos quimicos 251
NO20073722L (no) Farmasoystiske sammensetniger omfattende bendamustin
BRPI0915084B8 (pt) composto, e, composição farmacêutica
ECSP11010834A (es) Formulaciones farmacéuticas que contienen ligandos de receptores de dopamina
NO20090554L (no) Farmasoytiske preparater av memantin
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
EA201101341A1 (ru) Соединения, ингибирующие киназы, и фармацевтическая композиция на их основе
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
SV2011003855A (es) Heteroarilos sustituidos
BR122017015098B8 (pt) formulações farmacêuticas de liberação imediata que contêm hidrato de propileno glicol de dapagliflozina
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
CR11285A (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihipropiridina y metodo para la prepacion de la misma
BRPI0706992C8 (pt) composto de fórmula (i) e formulação farmacêutica
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
BRPI0916622A2 (pt) derivados de piperazina usados como moduladores de canal de cálcio cav2,2
GT200600119A (es) Composiciones farmaceuticas
AR070392A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion